Investor Relations

Find the latest funding information here.

For media enquiries please contact or call +41 79 592 2005

Allecra Therapeutics is a clinical stage biopharmaceutical company dedicated to the development of novel treatments to combat multi drug-resistant bacterial infections. Its lead product candidate is in Phase 2 clinical trials for the treatment of multi-drug-resistant Gram-negative bacterial infections in the hospital

09/06/2017 Allecra Announces Initiation of a Phase 2 Clinical Trial for its Novel Antibiotic to Treat Resistant Bacterial Infections

Download PDF

04/05/2017 Allecra Therapeutics Strengthens Leadership Team with Appointment of New Chairman and Chief Medical Officer

Download PDF

06/14/2016 Allecra Therapeutics Announces €22 Million Series B Financing

Download PDF